Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray

Exclusion Criteria

• •History of abnormal growth or gross malnutrition.
• •Clinically significant laboratory abnormality.
• •History of any condition that may have substantially affected growth.
• •Historical or current evidence of clinically significant, uncontrolled disease of any body system.
• •Any asthma other than mild, intermittent asthma controlled by short-acting, beta-agonists.
• •Recent major surgery and/or trauma to the legs.
• •History of adrenal insufficiency.
• •Current or prior treatment with any medication that may have a potential for an ongoing effect on linear growth.
• •Use of corticosteroids, by any route, within 4 weeks prior to Visit 1.
• •Any nasal condition or deformity that would impair nasal breathing or deposition of medication.
• •Physical impairment that would affect the subject's ability to participate in the study.